RecruitingEarly Phase 1NCT07190625

Intranasal Versus Intravenous Fentanyl For Procedural Analgesia in Preterm Neonates

Intranasal Versus Intravenous Fentanyl For Procedural Analgesia in Preterm Neonates : A Randomized Controlled Trial


Sponsor

Ain Shams University

Enrollment

75 participants

Start Date

Dec 24, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Pain in neonatal life has profound long-term developmental impacts, so pain control is crucial. The intranasal (IN) route is a minimally invasive method for rapidly delivering fentanyl to provide short-term analgesia and sedation in adults and pediatrics, but few data exist about its use in neonates. Meanwhile, intravenous fentanyl is widely used in sedation and pain management. Using intranasal fentanyl as an analgesic in preterm neonates may provide a rapid, effective, noninvasive route for administration.


Eligibility

Max Age: 28 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Fentanyl intranasal using atomizer, a drug called fentanyl intranasal direct, and others for people with procedural pain. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGfentanyl intravenous

giving intravenous fentanyl

DRUGFentanyl intranasal using atomizer

giving intranasal fentanyl using nasal atomizer

DRUGfentanyl intranasal direct

giving intranasal fentanyl directly into nostrils


Locations(1)

Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07190625


Related Trials